Higher genetic levels of plasma VIMP were linked to increased CRC risk, while decreased risks were found for other metabolic diseases, such as disorders of lipid metabolism, hyperlipidemia, hypercholesterolemia, and diseases affecting the circulatory system, including coronary atherosclerosis (Fig. 6). This evidence concerns the gene SELENOS and hyperlipidemia.